These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 19044051

  • 21. Using oseltamivir (Tamiflu) as a first line treatment for seasonal or pandemic flu.
    Greener M.
    Nurs Times; ; 105(34):22. PubMed ID: 19788111
    [No Abstract] [Full Text] [Related]

  • 22. Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation.
    Kawai N, Ikematsu H, Iwaki N, Kondou K, Hirotsu N, Kawashima T, Maeda T, Tanaka O, Doniwa K, Kashiwagi S.
    J Infect; 2009 Sep; 59(3):207-12. PubMed ID: 19619898
    [Abstract] [Full Text] [Related]

  • 23. Safety of influenza vaccination during pregnancy.
    Tamma PD, Ault KA, del Rio C, Steinhoff MC, Halsey NA, Omer SB.
    Am J Obstet Gynecol; 2009 Dec; 201(6):547-52. PubMed ID: 19850275
    [Abstract] [Full Text] [Related]

  • 24. Pandemic preparedness: toward a universal influenza vaccine.
    Roose K, Fiers W, Saelens X.
    Drug News Perspect; 2009 Mar; 22(2):80-92. PubMed ID: 19330167
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. M2e-based universal influenza A vaccine.
    Fiers W, De Filette M, El Bakkouri K, Schepens B, Roose K, Schotsaert M, Birkett A, Saelens X.
    Vaccine; 2009 Oct 23; 27(45):6280-3. PubMed ID: 19840661
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Disease caused by the new influenza A(H1N1) virus].
    Hauge SH, Dudman SG, Borgen K, Hungnes O, Brantsaeter A, Iversen B, Aavitsland P.
    Tidsskr Nor Laegeforen; 2009 Sep 10; 129(17):1736-9. PubMed ID: 19756053
    [Abstract] [Full Text] [Related]

  • 32. Expert judgments of pandemic influenza risks.
    Bruine De Bruin W, Fischhoff B, Brilliant L, Caruso D.
    Glob Public Health; 2006 Sep 10; 1(2):178-93. PubMed ID: 19153906
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Cost effectiveness of oseltamivir treatment of influenza: a critique of published methods and outcomes.
    Postma MJ, Beardsworth P, Wilschut JC.
    J Med Econ; 2008 Sep 10; 11(4):743-68. PubMed ID: 19450079
    [Abstract] [Full Text] [Related]

  • 35. Current status and progress of prepandemic and pandemic influenza vaccine development.
    Leroux-Roels I, Leroux-Roels G.
    Expert Rev Vaccines; 2009 Apr 10; 8(4):401-23. PubMed ID: 19348557
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Neuraminidase inhibitors for prevention of influenza?].
    Ziegler R.
    Med Monatsschr Pharm; 2005 Oct 10; 28(10):363. PubMed ID: 16245453
    [No Abstract] [Full Text] [Related]

  • 39. [On the prevention, early treatment and symptomatic management of influenza-like infections in industrial medicine].
    Otto W.
    Dtsch Med J; 1966 Mar 20; 17(6):179-80. PubMed ID: 5973782
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.